Danica Pension Livsforsikringsaktieselskab Buys Shares of 3,687,259 Alignment Healthcare, Inc. $ALHC

Danica Pension Livsforsikringsaktieselskab bought a new position in shares of Alignment Healthcare, Inc. (NASDAQ:ALHCFree Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 3,687,259 shares of the company’s stock, valued at approximately $87,794,000. Alignment Healthcare accounts for approximately 1.4% of Danica Pension Livsforsikringsaktieselskab’s investment portfolio, making the stock its 11th largest holding. Danica Pension Livsforsikringsaktieselskab owned 1.78% of Alignment Healthcare as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Summit Securities Group LLC bought a new stake in shares of Alignment Healthcare during the 4th quarter valued at about $26,000. Versant Capital Management Inc lifted its holdings in Alignment Healthcare by 463.3% in the second quarter. Versant Capital Management Inc now owns 1,380 shares of the company’s stock worth $33,000 after acquiring an additional 1,135 shares during the last quarter. Parallel Advisors LLC boosted its stake in Alignment Healthcare by 87.7% in the fourth quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock valued at $33,000 after acquiring an additional 773 shares during the period. Larson Financial Group LLC bought a new position in shares of Alignment Healthcare during the third quarter valued at approximately $33,000. Finally, First Horizon Corp acquired a new stake in shares of Alignment Healthcare during the 4th quarter worth approximately $39,000. 86.19% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, insider Hyong Kim sold 35,951 shares of the stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $19.86, for a total transaction of $713,986.86. Following the completion of the sale, the insider directly owned 331,750 shares of the company’s stock, valued at $6,588,555. This represents a 9.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Dawn Christine Maroney sold 30,000 shares of the firm’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $19.55, for a total transaction of $586,500.00. Following the sale, the president owned 947,313 shares of the company’s stock, valued at $18,519,969.15. The trade was a 3.07% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 1,009,951 shares of company stock worth $18,597,287. 5.20% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of research firms recently issued reports on ALHC. Barclays reduced their price objective on Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 26th. Weiss Ratings reissued a “hold (c-)” rating on shares of Alignment Healthcare in a report on Tuesday, August 4th. Raymond James Financial cut shares of Alignment Healthcare from a “strong-buy” rating to an “outperform” rating and dropped their price objective for the stock from $22.00 to $19.00 in a report on Monday, August 3rd. TD Cowen reissued a “buy” rating on shares of Alignment Healthcare in a research note on Monday, August 3rd. Finally, Zacks Research cut shares of Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 6th. Seven analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, Alignment Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $23.60.

Get Our Latest Analysis on Alignment Healthcare

Alignment Healthcare Trading Down 1.7%

Shares of ALHC stock opened at $13.23 on Wednesday. The stock has a 50-day simple moving average of $19.27 and a 200 day simple moving average of $19.00. Alignment Healthcare, Inc. has a fifty-two week low of $13.05 and a fifty-two week high of $25.12. The stock has a market capitalization of $2.74 billion, a P/E ratio of 69.64 and a beta of 1.10. The company has a quick ratio of 1.70, a current ratio of 1.70 and a debt-to-equity ratio of 1.22.

Alignment Healthcare (NASDAQ:ALHCGet Free Report) last issued its quarterly earnings results on Thursday, July 30th. The company reported $0.17 EPS for the quarter, topping the consensus estimate of $0.13 by $0.04. Alignment Healthcare had a net margin of 0.89% and a return on equity of 20.02%. The firm had revenue of $1.34 billion for the quarter, compared to analysts’ expectations of $1.31 billion. During the same period in the previous year, the business earned $0.07 earnings per share. Alignment Healthcare’s revenue for the quarter was up 31.6% compared to the same quarter last year. On average, sell-side analysts expect that Alignment Healthcare, Inc. will post 0.17 earnings per share for the current fiscal year.

About Alignment Healthcare

(Free Report)

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.

Read More

Institutional Ownership by Quarter for Alignment Healthcare (NASDAQ:ALHC)

Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.